Profile: Xiaoxia Chen has led the early discovery and preclinical research for several metabolic and tumor-targeted peptide drugs. She is not only proficient in high-throughput screening of peptide libraries but also sMOL Changesilled in utilizing AI-assisted computational biology for de novo peptide sequence design. Currently, Nws tab tom coj ib pab neeg tshwj xeeb rau MOL Changesev tshawb fawb tob thiab MOL Changesev tsim MOL Changesho tshiab ntawm cov tshuaj ua haujlwm ntau yam tshiab (xws li ob leeg- lossis peb hom hom peptides txo rog) thiab cov peptides MOL Changesho cov ntaub so ntswg muaj zog heev.
Tell us what you need — sequence, purity, quantity or assay — and our synthesis team will reply with a scoped quote within one business day. No online payment required.